170 related articles for article (PubMed ID: 2635732)
41. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
42. Hydrolysis of N-benzoyl-L-tyrosyl-para-aminobenzoic acid by rat kidney.
Imondi AR; Butler ER
Biochem Med; 1979 Oct; 22(2):198-203. PubMed ID: 316325
[No Abstract] [Full Text] [Related]
43. Synthesis, intestinal absorption and metabolism of sarcosine conjugated ursodeoxycholic acid.
Kimura M; Hatono S; Une M; Fukuoka C; Kuramoto T; Hoshita T
Steroids; 1984 Jun; 43(6):677-87. PubMed ID: 6533845
[TBL] [Abstract][Full Text] [Related]
44. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
Weizman Z; Forstner GG; Gaskin KJ; Kopelman H; Wong S; Durie PR
Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
[TBL] [Abstract][Full Text] [Related]
45. Residual function of exocrine pancreas after operation for chronic pancreatitis by N-benzoyl-L-tyrosyl-p-aminobenzoic acid test (NBT-PABA test).
Kodama M; Tanaka T
Digestion; 1984; 30(1):41-6. PubMed ID: 6333364
[TBL] [Abstract][Full Text] [Related]
46. Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine.
Caspary WF; Meyne K
Digestion; 1980; 20(3):168-74. PubMed ID: 7390046
[TBL] [Abstract][Full Text] [Related]
47. The effect of immunization with protein-hapten conjugate on the intestinal uptake of p-aminobenzoic acid as a hapten.
Yamamoto A; Sakane T; Kawaratani T; Aisaka A; Hashida M; Sezaki H
Life Sci; 1989; 44(2):121-30. PubMed ID: 2783756
[TBL] [Abstract][Full Text] [Related]
48. Urinary p-aminobenzoic acid determined in the pancreatic function test by liquid chromatography, with electrochemical detection.
Ito S; Maruta K; Imai Y; Kato T; Ito M; Nakajima S; Fujita K; Kurahashi T
Clin Chem; 1982 Feb; 28(2):323-6. PubMed ID: 6976857
[TBL] [Abstract][Full Text] [Related]
49. A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon.
Asciutti S; Castellani D; Nardi E; Morelli O; Clementi M; Chistolini F; Gentili G; Setchell KD; O'Connell N; Pellicciari R; Clerici C
Anticancer Res; 2009 Dec; 29(12):4971-9. PubMed ID: 20044604
[TBL] [Abstract][Full Text] [Related]
50. Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test.
Koren G; Weizman Z; Forstner G; MacLeod SM; Durie PR
Dig Dis Sci; 1985 Oct; 30(10):928-32. PubMed ID: 3875462
[TBL] [Abstract][Full Text] [Related]
51. [Metabolism of bile acids. XIV. Sarcosine conjugated bile acids].
Hatono S; Hironaka Y; Kuramoto T; Hoshita T
Yakugaku Zasshi; 1984 May; 104(5):466-71. PubMed ID: 6491885
[No Abstract] [Full Text] [Related]
52. A difference in stimulatory effects on pancreatic exocrine secretion between ursodeoxycholate and trypsin inhibitor in the rat.
Miyasaka K; Kitani K
Dig Dis Sci; 1986 Sep; 31(9):978-86. PubMed ID: 2426065
[TBL] [Abstract][Full Text] [Related]
53. Relationship between PABA and Lundh tests: lack of influence of duodenal pH in vivo.
Kay GH; Tetlow VA; Braganza JM
Clin Chim Acta; 1983 Feb; 128(1):115-24. PubMed ID: 6601548
[TBL] [Abstract][Full Text] [Related]
54. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
55. Bile acids with a cyclopropyl-containing side chain. 3. Separation, identification, and properties of all four stereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid.
Pellicciari R; Natalini B; Cecchetti S; Porter B; Roda A; Grigolo B; Balducci R
J Med Chem; 1988 Apr; 31(4):730-6. PubMed ID: 3351848
[TBL] [Abstract][Full Text] [Related]
56. Observations on the BT PABA/14C-PABA tubeless test of pancreatic function.
Braganza JM; Kay GH; Tetlow VA; Herman KJ
Clin Chim Acta; 1983 Jun; 130(3):339-47. PubMed ID: 6603288
[TBL] [Abstract][Full Text] [Related]
57. [Clinical studies on the exocrine pancreatic function test by oral administration of N-benzoyl-L-tyrosyl-PABA combined with the PABA absorption test (author's transl)].
Kimura T; Wakasugi H; Funakoshi A; Matsumoto M; Ibayashi H
Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):259-65. PubMed ID: 312346
[No Abstract] [Full Text] [Related]
58. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
Kubaska WM; Gurley EC; Hylemon PB; Heuman DM; Mosbach EH; Vlahcevic ZR
Biochim Biophys Acta; 1987 Aug; 920(3):195-204. PubMed ID: 3607077
[TBL] [Abstract][Full Text] [Related]
59. Absorption and metabolism of procaine by the rat small intestine.
Rummel J; Büch HP
Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):228-33. PubMed ID: 2234105
[TBL] [Abstract][Full Text] [Related]
60. Effect of ursodeoxycholic acid (UDCA) on pancreatic enzyme secretion and gallbladder emptying.
Lanzini A; Hall N; Facchinetti D; Northfield TC
Pancreas; 1990 Mar; 5(2):128-35. PubMed ID: 2315289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
